Related Experiment Video
Updated: Jul 16, 2026

Testing the Efficacy of Pharmacological Agents in a Pericardial Target Delivery Model in the Swine
Published on: July 7, 2016
New Cardiac Glycosides from Digitalis lanata
1Institut für Pharmazeutische Biologie der Philipps-Universität Marburg/Lahn, D-3550 Marburg.
Two novel cardenolides were identified and structurally characterized from the leaves of Digitalis lanata Ehrh. using thin-layer chromatography (TLC) and spectroscopic techniques.
Area of Science:
- Phytochemistry
- Natural Product Chemistry
- Pharmacognosy
Background:
- Digitalis lanata Ehrh. is a plant species known for its cardiac glycoside content.
- Cardenolides are a class of naturally occurring compounds with significant pharmacological activities.
- Previous research has explored the chemical constituents of Digitalis species.
Purpose of the Study:
- To isolate and elucidate the structures of new cardenolide compounds from Digitalis lanata Ehrh.
- To contribute to the understanding of the phytochemical diversity within the Digitalis genus.
- To identify potential new lead compounds for drug discovery.
Main Methods:
- Extraction of compounds from the leaves of Digitalis lanata Ehrh.
- Separation and purification using thin-layer chromatography (TLC).
- Structural elucidation employing various spectroscopic methods (e.g., NMR, Mass Spectrometry).
Main Results:
- Two previously undescribed cardenolides were successfully isolated.
- The chemical structures were determined to be Digoxigenin-3-O-beta-D-digitoxosido-beta-D-digitoxosido-beta-D-xyloside.
- The findings expand the known repertoire of cardenolides from this plant source.
Conclusions:
- The study successfully identified and characterized two new cardenolides from Digitalis lanata Ehrh.
- These findings enhance our knowledge of the chemical constituents of Digitalis lanata.
- The newly discovered compounds may hold potential for future pharmacological investigations.
Related Concept Videos
Heart Failure Drugs: Inotropic Agents
Antiarrhythmic Drugs: Class II Agents as β-Adrenergic Blockers
Antiarrhythmic Drugs: Class III Agents as Potassium Channel Blockers
Antianginal Drugs: Nitrates and β-Blockers
Organic nitrates, such as nitroglycerin, play a pivotal role. Once metabolized, they liberate nitric oxide, a molecular marvel. Nitric oxide triggers guanylyl cyclase and augments cGMP production. This biochemical cascade orchestrates the relaxation of vascular smooth muscles, ushering in vasodilation and enhancing coronary blood flow. Administered...
Adrenergic Antagonists: ɑ and β-Receptor Blockers
Antiarrhythmic Drugs: Class IV Agents as Calcium Channel Blockers
Verapamil, a calcium channel blocker, inhibits calcium movement across myocardial cell membranes and vascular smooth muscle. This results in the dilation of coronary and...